Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase NA 1Phase 2 1

Status

Completed 19Unknown 18Recruiting 15Not yet recruiting 7Terminated 6Withdrawn 5Active not recruiting 5Enrolling by invitation 1

Sponsor Class

OTHER 5INDUSTRY 2

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 5Other solid neoplasm 1

Conditions

Breast Neoplasms 629Prostatic Neoplasms 371Neoplasms 307Carcinoma, Non-Small-Cell Lung 215Lung Neoplasms 204Colorectal Neoplasms 176Multiple Myeloma 144Pancreatic Neoplasms 136Leukemia, Myeloid, Acute 128Neoplasm Metastasis 124Brain Neoplasms 117Melanoma 116Ovarian Neoplasms 103Carcinoma, Hepatocellular 102Precursor Cell Lymphoblastic Leukemia-Lymphoma 100Glioblastoma 99Uterine Cervical Neoplasms 97Head and Neck Neoplasms 95Squamous Cell Carcinoma of Head and Neck 94Colonic Neoplasms 81Stomach Neoplasms 80Recurrence 80Rectal Neoplasms 80Urinary Bladder Neoplasms 77Sarcoma 77Triple Negative Breast Neoplasms 75Carcinoma, Renal Cell 75Lymphoma 71Leukemia, Lymphocytic, Chronic, B-Cell 68Lymphoma, Non-Hodgkin 67

Interventions

Capecitabine 2Bevacizumab 2trifluridine tipiracil drug combination 1sintilimab 1Transurethral Resection of Prostate 1Tomography, X-Ray Computed 1Oxaliplatin 1Nivolumab 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Colorectal Cancer Metastatic × Clear all
NCT04564898 2026-05-20

TriComB

Gruppo Oncologico del Nord-Ovest

Phase 1/2 Active not recruiting
48 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT03038568 2026-04-22

Assessing How Normal Variations in CT Scanning Affects Its Interpretation

Memorial Sloan Kettering Cancer Center

Active not recruiting
169 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT05129787 2026-02-12

NEW-COMET

Oslo University Hospital

Phase NA Active not recruiting
230 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT04730544 2025-06-13

NIPISAFE

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Active not recruiting
96 enrolled
GastrointestinalOther solid neoplasm

Colorectal Cancer Metastatic

NCT04940546 2024-12-03

Neoadjuvant Safety of Sintilimab + XELOX + Bevacizumab in PMMR/MSS CRLM Patients

Sun Yat-sen University

Phase 1/2 Active not recruiting
36 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡